Clinical Trials
Early trials find Russia’s Sputnik V safe, volunteers develop coronavirus antibodies within 3 weeks
Much buzz was created around the world when Russia claimed to have approved the first COVID-19 vaccine around the world, for public use. Experts and researchers from around the world questioned the efficacy and safety of the vaccine, dubbed...
News
CureVac to Receive 252million Euros to Support COVID-19 Vax Development
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) in clinical trials, has received notification from the German Federal Ministry of Education and Research (BMBF) that CureVac is expected receive...
News
World’s Largest Virtual Pharma Expo Agenda Unveiled
CPhI Festival of Pharma (5-16 October, 2020), the world’s largest ever virtual pharma expo, unveils its ground-breaking two-week long agenda. The newly launched and rapidly created virtual event will provide the global pharma community with a vital platform to...
News
Bristol Myers Gets FDA Approval for Oral AML Therapy Onureg
Bristol Myers Squibb announced that the U.S. FDA has approved Onureg® (azacitidine 300 mg tablets, CC-486) for the continued treatment of adult patients with acute myeloid leukemia (AML) who achieved first complete remission (CR) or CR with incomplete blood...
News
BCG vaccine safe for elderly, can protect against respiratory infections
The BCG vaccine, which is frequently given to children to prevent tuberculosis, is safe to give to the elderly, and can protect them against various infections, according to a study which says it may have a broad, stimulating effect...
Drug Research
Ohio State University researchers working on promising COVID-19 vaccine
An experimental vaccine under research at The Ohio State University has shown the potential to be an option moving forward in the quest to stamp out COVID-19.
Researchers have used an engineering technique that allows for manipulation of the messenger...
News
Johnson & Johnson Announces Agreement in Principle with Government of Canada to Supply its COVID-19 Vaccine Candidate
Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has agreed in principle to supply the Government of Canada with doses of its SARS-CoV-2 vaccine candidate, Ad26.COV2.S. The availability of the vaccine candidate is subject to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.